Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19

This article featuring Providence researchers presents an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during the first week of infection following diagnosis. This study suggests that moderate disease may provide the most effective setting for therapeutic intervention.